Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Smith & Nephew slumps on Chinese weakness

Published 10/31/2024, 06:44 PM
© Reuters.
UK100
-
SN
-

Investing.com - Smith & Nephew (LON:SN) stock slumped Thursday after the UK-based medical equipment manufacturer slashed its full-year revenue guidance, citing weakness in the important Chinese market.

At 06:40 ET (10:40 GMT), S&N stock fell over 12% to £9.59, the largest one-day percentage fall since October 1987. 

The FTSE 100-listed company now expects underlying revenue growth for 2024 of around 4.5% instead of in between 5.0% and 6.0%. 

It has also heavily revised its full-year profit margin growth target for 2024, anticipating trading profit margin growth of up to 0.5% from last year's 17.5%, having previously forecast a margin of at least 18%. 

For the three months ended Sept. 30 revenue rose to $1.41 billion from $1.36 billion, representing an underlying and reported growth of 4%. Excluding China, group growth was 5.9%.

Chief executive Deepak Nath said: “While the revised outlook reflects the challenges we continue to face across our surgical businesses in China, we remain convinced that our transformation will position us as a higher growth company, with the ability to drive operating leverage through to the bottom line over time.”

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.